Article
A prognostic score including mutation profile and clinical features for patients with CMML undergoing stem cell transplantation.
Blood advances - 23 Mar 2021
Gagelmann Nico, Badbaran Anita, Beelen Dietrich W, Salit Rachel B, Stölzel Friedrich, Rautenberg Christina, Becker Heiko, Radujkovic Aleksandar, Panagiota Victoria, Bogdanov Rashit, Christopeit Maximilian, Park Yong, Nibourel Olivier, Luft Thomas, Koldehoff Michael, Corsten Maarten, Heuser Michael, Finke Jürgen, Kobbe Guido, Platzbecker Uwe, Robin Marie, Scott Bart L, Kröger Nicolaus
Abstract excerpt
The inclusion of mutation status improved risk stratification for newly diagnosed patients with chronic myelomonocytic leukemia (CMML). Stem cell transplantation is a potentially curative treatment option, and patient selection is critical because of relevant transplant-related morbidity and mortality. We aimed to evaluate the impact of mutation status together with clinical presentations on posttransplant...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.